Beacon Capital Management LLC (Tennessee)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Beacon Capital Management LLC (Tennessee)'s ABBV Position: Q2 2026 in Review
Beacon Capital Management LLC (Tennessee) reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $57.2K and leaving 2,193 shares worth $552K. The position accounts for 0.08% of the portfolio, ranked #89.
Beacon Capital Management LLC (Tennessee) first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $626K in Q4 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) held 2,193 shares of AbbVie worth $552K as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) sold 266 AbbVie shares in Q2 2026, an estimated $57.2K.
- AbbVie made up 0.08% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #89 holding.
- Beacon Capital Management LLC (Tennessee) first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- Beacon Capital Management LLC (Tennessee)'s AbbVie position peaked at $626K in Q4 2022.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.